Notes - Segment Information

Astellas Pharma Inc. - Filing #7551605

Concept As at
2023-06-30
2023-04-01 to
2023-06-30
As at
2023-03-31
2022-04-01 to
2022-06-30
Notes - Segment information
Segment information
Revenue
Revenue
374,990,000,000 JPY
381,791,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
686,000,000 JPY
350,000,000 JPY
Profit (loss) before tax
46,850,000,000 JPY
31,679,000,000 JPY
Assets
2,797,958,000,000 JPY
2,456,518,000,000 JPY
Investments accounted for using equity method
14,715,000,000 JPY
12,689,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.